Disulfiram is a prescription drug used to support treatment for chronic alcohol dependence. Marketed under brand names such as Antabuse, it is not a stand‑alone cure but a tool intended to discourage drinking by producing an immediate and unpleasant physiological response when alcohol is consumed. Treatment with disulfiram is normally part of a broader program that includes counselling, social support, and medical supervision.
How it works
Disulfiram blocks an enzyme involved in alcohol metabolism, causing acetaldehyde — a toxic intermediate — to accumulate if a person drinks ethanol. This accumulation produces a predictable cluster of symptoms that can include flushing, nausea, headache, and rapid heart rate. The effect is intended to create an aversive association with drinking and to deter relapse. The medication begins to act after it reaches therapeutic levels in the body and the reaction can occur for some time after a dose.
Uses and administration
Disulfiram is prescribed as part of a supervised treatment plan for adults diagnosed with alcohol use disorder who are motivated to avoid drinking. Dosing and duration vary by patient and clinical judgement. Treatment often starts after a period of abstinence and under medical supervision because drinking too soon after beginning disulfiram increases the risk of a severe reaction. Medical teams commonly combine pharmacotherapy with behavioural interventions, peer support, or formal counselling programs (see support options).
Safety profile and adverse effects
When taken as directed, many people tolerate disulfiram, but it can cause side effects and has specific contraindications. Common and possible reactions include:
- Nausea, vomiting, and abdominal discomfort
- Facial flushing, headache, and palpitations
- Fatigue, drowsiness, or changes in taste
More serious effects — though less common — may include liver enzyme abnormalities and severe cardiovascular responses if alcohol is consumed while taking the drug. People with certain medical conditions or those taking particular medicines should not use disulfiram; clinicians evaluate risks before prescribing. For a plain overview of risks and precautions consult a reliable prescribing information source (safety summary).
Interactions, monitoring and follow-up
Disulfiram interacts with ethanol but also with several medications and substances. Patients are routinely advised to avoid all forms of alcohol, including present in sauces, cough syrups, or topical products. Health professionals monitor liver function and check for other adverse effects during treatment. Because adherence is crucial, supervised dosing or family involvement is sometimes used. Clinical follow‑up often addresses both medical and psychosocial aspects of recovery (clinical guidance).
History and notable distinctions
Disulfiram originated from industrial chemistry observations and was developed for medical use as an aversion agent. It differs from other pharmacotherapies for alcohol dependence — such as opioid antagonists or modulators of glutamate transmission — by producing an immediate deterrent effect rather than directly reducing craving. Its best outcomes occur when patients are engaged in comprehensive treatment that includes counselling and long‑term support. For more detailed background or treatment resources see summaries and reviews provided by healthcare organizations (further reading).